6204 related articles for article (PubMed ID: 3260822)
1. Destruction of tumor cells by monokines released from activated human blood monocytes: evidence for parallel and additive effects of IL-1 and TNF.
Ichinose Y; Tsao JY; Fidler IJ
Cancer Immunol Immunother; 1988; 27(1):7-12. PubMed ID: 3260822
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
Ichinose Y; Bakouche O; Tsao JY; Fidler IJ
J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254
[TBL] [Abstract][Full Text] [Related]
3. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
Chen AR; McKinnon KP; Koren HS
J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
[TBL] [Abstract][Full Text] [Related]
5. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
Nii A; Fidler IJ
Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 beta- and tumor necrosis factor-alpha-independent monocyte stimulation of fibroblast collagenase activity.
Tipton DA; Pabst MJ; Dabbous MK
J Cell Biochem; 1990 Dec; 44(4):253-64. PubMed ID: 1965653
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes.
te Velde AA; Huijbens RJ; Heije K; de Vries JE; Figdor CG
Blood; 1990 Oct; 76(7):1392-7. PubMed ID: 2119829
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.
Philip R; Epstein LB
Nature; 1986 Sep 4-10; 323(6083):86-9. PubMed ID: 3092113
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of macrophage-mediated tumor cell lysis: role for the monokines tumor necrosis factor and interleukin 1.
Fidler IJ; Ichinose Y
Prog Clin Biol Res; 1989; 288():169-81. PubMed ID: 2785689
[No Abstract] [Full Text] [Related]
11. Role of IFN gamma on TNF alpha, IL-1 beta and IL-6 release during HHV-6 infection.
Arena A; Capozza AB; Di Luca D
New Microbiol; 1996 Jul; 19(3):183-91. PubMed ID: 8841033
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation.
Rathanaswami P; Hachicha M; Wong WL; Schall TJ; McColl SR
Arthritis Rheum; 1993 Sep; 36(9):1295-304. PubMed ID: 8216423
[TBL] [Abstract][Full Text] [Related]
13. Tumor cytotoxicity of human monocyte membrane-bound interleukin-1 alpha induced by synergistic actions of interferon-gamma and synthetic acyltripeptide, FK-565.
Inamura N; Sone S; Okubo A; Kunishige E; Nakanishi M; Ogura T
Cancer Immunol Immunother; 1989; 28(3):164-70. PubMed ID: 2493987
[TBL] [Abstract][Full Text] [Related]
14. Glucose kinetics in rats infused with endotoxin-induced monokines or tumor necrosis factor.
Bagby GJ; Lang CH; Hargrove DM; Thompson JJ; Wilson LA; Spitzer JJ
Circ Shock; 1988 Feb; 24(2):111-21. PubMed ID: 3370760
[TBL] [Abstract][Full Text] [Related]
15. Human MCF activates monocytes to produce IL-1 but not TNF or CSF-1.
Jones CM; Poddar S; Goldstein R; Krupen KI; Kerman RH; Prince C; Shadduck RK
Immunobiology; 1994 Jun; 190(4-5):303-16. PubMed ID: 7982717
[TBL] [Abstract][Full Text] [Related]
16. On the role of monokines in the generation of nonspecific suppressor T cell activity in vitro.
Baxevanis CN; Dedousis GV; Gritzapis AD; Papadopoulos NG; Arsenis P; Katsiyiannis A; Papamichail M
Immunopharmacol Immunotoxicol; 1994 May; 16(2):225-45. PubMed ID: 8077608
[TBL] [Abstract][Full Text] [Related]
17. Effect of interferon-gamma priming on the activation of murine peritoneal macrophages to tumouricidal state by cisplatin, IL-1, and tumour necrosis factor (TNF): production of IL-1 and TNF.
Sodhi A; Singh RK; Singh SM
Clin Exp Immunol; 1992 May; 88(2):350-5. PubMed ID: 1572101
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
19. In vitro modulation of human monocytes functions by RU 41740 (Biostim).
Sozzani S; D'Alessandro F; Capsoni F; Luini W; Barcellini W; Guidi G; Spreafico F
Int J Immunopharmacol; 1988; 10(2):93-102. PubMed ID: 3259556
[TBL] [Abstract][Full Text] [Related]
20. Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines.
Häupl T; Landgraf S; Netusil P; Biller N; Capiau C; Desmons P; Hauser P; Burmester GR
FEMS Immunol Med Microbiol; 1997 Sep; 19(1):15-23. PubMed ID: 9322065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
